Navigation Links
Rensselaer Polytechnic Institute professor Peter M. Tessier named Pew Scholar
Date:6/17/2010

Troy, N.Y. Peter M. Tessier, assistant professor of chemical and biological engineering at Rensselaer Polytechnic Institute, has been named a 2010 Pew Scholar in the Biomedical Sciences by the Pew Charitable Trusts.

The distinction includes an award of $240,000 over four years and inclusion into a select community of scientists that includes three Nobel Prize winners, three MacArthur Fellows, and two recipients of the Albert Lasker Medical Research Award, according to the Pew Charitable Trusts.

"We congratulate Dr. Tessier for being selected as a Pew Scholar in Biomedical Sciences, an honor reserved for the most promising young faculty in the biomedical field," said David Rosowsky, dean of the School of Engineering at Rensselaer. "We are extremely proud of Peter for being named a Pew Scholar as well as his recent CAREER Award from the National Science Foundation and we look forward to his continued development as a leading scholar and researcher. Dr. Tessier's recent recognitions are further evidence of the very high caliber of faculty we are attracting to Rensselaer."

Tessier joined the Rensselaer faculty in 2007 following a postdoctoral fellowship at the Massachusetts Institute of Technology's Whitehead Institute for Biomedical Research. He received his bachelor's degree in chemical engineering from the University of Maine, and went on to earn his doctoral degree in chemical engineering from the University of Delaware.

Tessier is investigating fundamental aspects of misfolding and clumping of three classes of proteins, long strings of molecules that participate in virtually every cellular process. Proteins fold into complex, three-dimensional structures, which is required for their proper function. Defects in the folding process can occur, which creates toxic protein clumps that are the basis of disorders ranging from Alzheimer's disease to glaucoma.

Tessier's immediate goal is to understand how the incorrect processing of proteins can be prevented, reversed, or redirected. His long-term objective is to develop new therapies to treat diseases related to toxic protein aggregation.

The Pew Scholars program enables scientists to take calculated risks, expand their research, and explore unanticipated leads. According to Pew, the program now in its 25th year has invested more than $125 million to fund nearly 500 scholars. Many of the nation's best early-career scientistsworking in all areas of physical and life sciences related to biomedical researchapply to the rigorously competitive program. Applicants are nominated by one of 155 invited institutions and demonstrate excellence and innovation in their research.

"Twenty-five years ago, the Pew Charitable Trusts identified a tremendous opportunity to impact the world of science by supporting the most promising young investigators and encouraging them to pursue their best ideas without restrictions," said Rebecca W. Rimel, president and CEO of the Pew Charitable Trusts. "Motivating scientists at this point in their careers is essential to advancing discovery and innovation, and Pew is honored to continue its commitment to this cadre of high-quality researchers."

Earlier this year, Tessier was also awarded a five-year, $411,872 Faculty Early Career Development Award (CAREER) from the National Science Foundation (NSF) to further his research into protein thermodynamics and aggregation.


'/>"/>

Contact: Mary Martialay
martialay@earthlink.net
518-276-2176
Rensselaer Polytechnic Institute
Source:Eurekalert

Related biology news :

1. Rensselaer Polytechnic Institute professor Patrick Underhill receives NSF CAREER award
2. Rensselaer Polytechnic Institute wins $2.45 million grant to support stem cell research
3. Rensselaer researchers to send bacteria into orbit aboard space shuttle Atlantis
4. Rensselaer leads effort to replace 1 of the most widely used drugs in American hospitals
5. Rensselaer receives more than $2 million from New York State to fund stem cell research
6. Trustee makes donation to start new solar energy research center at Rensselaer
7. Deadly dose: Rensselaer heparin expert helps uncover source of lethal contamination
8. Gladstone and Institute for Systems Biology collaborate on Huntingtons disease
9. National Eye Institute hosts Translational Research and Vision Symposium
10. University of Washington institute to get as much as $100 million to study atmosphere, ocean
11. Norwegian Institute of Public Health receives $100,000 Grand Challenges Explorations grant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2016)... and WARSAW, Poland , Nov. 30, 2016 ... is one of the most crucial aspects of recovery so we need to do ... serious health risks, including heart problems, high blood pressure, stroke, diabetes, and even cancer. ... friends sleep and find a Christmas present that could help them to manage their ... ...
(Date:11/28/2016)... "The biometric system market projected to ... system market is in the growth stage and is ... biometric system market is expected to be valued at ... 16.79% between 2016 and 2022. Government initiative in adoption ... rising use of biometric technology in financial institutes and ...
(Date:11/19/2016)... , Nov. 18, 2016 Securus Technologies, a ... for public safety, investigation, corrections and monitoring, announced today ... competitor, ICSolutions, to have an independent technology judge determine ... most modern high tech/sophisticated telephone calling platform, and the ... that they do most of what we do – ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... 1, 2016   SurePure, Inc. (OTCQB: SURP) ... the Company has concluded an agreement with Tamarack Biotics ... 90-day period to acquire units of the Company,s patented ... 3.7 million.  Concurrently with the option, ... which Tamarack will seek regulatory approvals in ...
(Date:11/30/2016)... 30, 2016 The global Pyrogen ... hold a dominant share in the overall market. The ... Inc., and Merck KGaA, held a lion,s share of ... Research observes that these companies are expected to retain ... that are do not require rabbit pyrogen testing along ...
(Date:11/30/2016)... 30, 2016  Tempus, a technology company focused ... Penn,s Abramson Cancer Center have partnered to better ... to immunotherapy treatment based on next generation genomic ... of a research collaboration, Tempus will provide sequencing ... patient data to Penn. Utilizing next-generation sequencing, machine ...
(Date:11/30/2016)... IN (PRWEB) , ... November 30, 2016 , ... SSCI, ... experts to discuss the implications of the latest FDA guidance on pharmaceutical cocrystals ... 8, 2016 in Cambridge, MA. , The event follows the successful November ...
Breaking Biology Technology: